Intervention Review

Valproate for acute mood episodes in bipolar disorder

  1. Karine Macritchie1,
  2. John Geddes2,
  3. Jan Scott3,
  4. D R Haslam4,
  5. Mauricio Silva de Lima5,
  6. Guy Goodwin6

Editorial Group: Cochrane Common Mental Disorders Group

Published Online: 20 JAN 2003

Assessed as up-to-date: 7 SEP 2002

DOI: 10.1002/14651858.CD004052

How to Cite

Macritchie K, Geddes J, Scott J, Haslam DR, Silva de Lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD004052. DOI: 10.1002/14651858.CD004052.

Author Information

  1. 1

    King’s College, c/o Ms Caroline Loveland, Centre for Affective Disorders, Institute of Psychiatry, London, UK

  2. 2

    University of Oxford/Warneford Hospital, Department of Psychiatry, Oxford, UK

  3. 3

    Newcastle University, Academic Psychiatry, Newcastle Upon Tyne, UK

  4. 4

    University of British Columbia, Department of Psychiatry, Vancouver, BC, Canada

  5. 5

    Genentech, US Medical Affairs, South San Francisco, California, USA

  6. 6

    University of Oxford, Department of Psychiatry, Oxford, Oxon, UK

*Keith Reid, Bamburgh Clinic, Northumberland Tyne and Wear NHS Foundation Trust, Jubilee Road, Newcastle, NE3 3XT, UK.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 20 JAN 2003


Cited in:


This article has been cited by:

  1. 1
    Diana Balasubramanian, Alicia X. Deng, Kit Doudney, Mark B. Hampton, Martin A. Kennedy, Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line, Neuropharmacology, 2015, 99, 79


  2. 2
    Mathias Berger, Dietrich van Calker, Eva-Lotta Brakemeier, Elisabeth Schramm, Psychische Erkrankungen, 2015,


  3. 3
    Dietrich van Calker, Psychische Erkrankungen, 2015,


  4. 4
    J. Connaughton, S. Patman, C. Pardoe, Are there associations among physical activity, fatigue, sleep quality and pain in people with mental illness? A pilot study, Journal of Psychiatric and Mental Health Nursing, 2014, 21, 8
  5. 5
    Ramadhan Oruch, Mahmoud A. Elderbi, Hassan A. Khattab, Ian F. Pryme, Anders Lund, Lithium: A review of pharmacology, clinical uses, and toxicity, European Journal of Pharmacology, 2014, 740, 464


  6. 6
    Kane O. Pryor, Kingsley P. Storer, Pharmacology and Physiology for Anesthesia, 2013,


  7. 7
    John A. Bostrom, Monsheel Sodhi, Pharmacogenomics, 2013,


  8. 8
    Gin S Malhi, Danielle M Bargh, Roger McIntyre, Michael Gitlin, Mark A Frye, Michael Bauer, Michael Berk, Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder, Bipolar Disorders, 2012, 14,
  9. 9
    Dietrich van Calker, Jörg Walden, Psychische Erkrankungen, 2012,


  10. 10
    Mathias Berger, Dietrich van Calker, Eva-Lotta Brakemeier, Elisabeth Schramm, Psychische Erkrankungen, 2012,


  11. 11
    Christoph U Correll, Eva M Sheridan, Melissa P DelBello, Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials, Bipolar Disorders, 2010, 12, 2
  12. 12
    Despina G. Contopoulos-Ioannidis, Maria S. Baltogianni, John P.A. Ioannidis, Comparative Effectiveness of Medical Interventions in Adults Versus Children, The Journal of Pediatrics, 2010, 157, 2, 322


  13. 13
    Susmit Sekhar, Bhupinder Kalra, D. N. Mendhekar, Uma Tekur, Efficacy of Sodium Valproate and Haloperidol in the Management of Acute Mania: A Randomized Open-Label Comparative Study, The Journal of Clinical Pharmacology, 2010, 50, 6
  14. 14
    G. S. Malhi, D. Adams, L. Lampe, M. Paton, N. O’Connor, L. A. Newton, G. Walter, A. Taylor, R. Porter, R. T. Mulder, M. Berk, Clinical practice recommendations for bipolar disorder, Acta Psychiatrica Scandinavica, 2009, 119,
  15. You have free access to this content15
    Joel Handler, Lithium and Antihypertensive Medication: A Potentially Dangerous Interaction, The Journal of Clinical Hypertension, 2009, 11, 12
  16. 16
    Sanne Piepers, Jan H. Veldink, Sonja W. De Jong, Ingeborg Van Der Tweel, W-Ludo Van Der Pol, Esther V. Uijtendaal, H. Jurgen Schelhaas, Hans Scheffer, Marianne De Visser, J. M. B. Vianney De Jong, John H. J. Wokke, Geert Jan Groeneveld, Leonard H. Van Den Berg, Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis, Annals of Neurology, 2009, 66, 2
  17. 17
    Peixiong Yuan, Giacomo Salvadore, Xiaoxia Li, Lei Zhang, Jing Du, Guang Chen, Husseini K Manji, Valproate activates the Notch3/c-FLIP signaling cascade: a strategy to attenuate white matter hyperintensities in bipolar disorder in late life?, Bipolar Disorders, 2009, 11, 3
  18. 18
    Marc Roy, Daniel Leclerc, Qing Wu, Sapna Gupta, Warren D. Kruger, Rima Rozen, Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency, Journal of Cellular Biochemistry, 2008, 105, 2
  19. 19
    Kate Seddon, David Nutt, Pharmacological treatment of bipolar disorder, Psychiatry, 2007, 6, 7, 305


  20. 20
    Xavier Castells, Antoni Vallano, David Rigau, Joselin Pérez, Miguel Casas, Dolors Capellà, Trends in lithium prescription in Spain from 1985 to 2003, Journal of Affective Disorders, 2006, 91, 2-3, 273


  21. 21
    Lakshmi N Yatham, Sidney H Kennedy, Claire O'Donovan, Sagar Parikh, Glenda MacQueen, Roger McIntyre, Verinder Sharma, Peter Silverstone, Martin Alda, Philippe Baruch, Serge Beaulieu, Andree Daigneault, Roumen Milev, L. Trevor Young, Arun Ravindran, Ayal Schaffer, Mary Connolly, Chris P Gorman, Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies, Bipolar Disorders, 2005, 7,
  22. 22
    Diane C. Lagace, W. Timothy O'Brien, Nadia Gurvich, Mark W. Nachtigal, Peter S. Klein, Valproic acid: how it works. Or not, Clinical Neuroscience Research, 2004, 4, 3-4, 215


  23. 23
    P Montgomery, AJ Richardson, MA Ross, Omega-3 fatty acids for bipolar disorder, The Cochrane Library,
  24. 24
    Paul Montgomery, Alexandra J Richardson, Omega-3 fatty acids for bipolar disorder, The Cochrane Library,
  25. 25
    Akshya Vasudev, Karine Macritchie, Sanjay K Rao, John Geddes, Allan H Young, Tiagabine for acute affective episodes in bipolar disorder, The Cochrane Library,
  26. 26
    Akshya Vasudev, Karine Macritchie, Sanjay NK Rao, John Geddes, Allan H Young, Tiagabine in the maintenance treatment of bipolar disorder, The Cochrane Library,